Current Editions
White House fails to bring mid-tier biotechs to MFN table
Contrary to administration leaks, high-profile mid-sized biotechs were conspicuous by their absence at a White House press conference
Politics, Policy & Law
Politics, Policy & Law
MFN deals, Lilly takeout, FDA pick Overton — a BioCentury podcast
Monday’s drug pricing reveal by White House short on U.S. biopharmas
Deals
Lilly’s deal spree continues with Merida takeout: Deals Report
Haisco, Duality feature in cross-border deals; and more
BioCentury ISSN 1097-7201